Cargando…

Ferric citrate controls serum phosphorus in dialysis patients: retrospective data

Ferric citrate is an approved phosphate binder for use in patients with chronic kidney disease on dialysis. Clinical trials demonstrated that ferric citrate controlled serum phosphorus levels and increased iron stores. The aim of this retrospective chart review was to evaluate real-world bone minera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hain, Debra J., Marinaro, Meredith, Koeper, David W., Rosenthal, Melissa A., Chillemi, Salvatore, Huffman, Jennifer M., Gerbeling, Teresa, Pritsiolas, James M., Loram, Lisa C., Pergola, Pablo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467155/ https://www.ncbi.nlm.nih.gov/pubmed/28561732 http://dx.doi.org/10.5414/CN109057

Ejemplares similares

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
por: Chertow, Glenn M., et al.
Publicado: (2017)

Conventional and novel impacts of ferric citrate on iron deficiency anemia and phosphorus metabolism in rats
por: IIDA, Akio, et al.
Publicado: (2020)

Antiviral effects of ferric ammonium citrate
por: Wang, Hongbin, et al.
Publicado: (2018)

Physicochemical characterization of ferric pyrophosphate citrate
por: Gupta, Ajay, et al.
Publicado: (2018)

Ferric pyrophosphate citrate: interactions with transferrin
por: Pratt, Raymond, et al.
Publicado: (2018)

Hemoglobin response to ferric citrate in patients with nondialysis‐dependent chronic kidney disease and iron deficiency anemia
por: Pergola, Pablo E., et al.
Publicado: (2018)

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses
por: Block, Geoffrey A, et al.
Publicado: (2019)

Mechanism of Action and Clinical Attributes of Auryxia(®) (Ferric Citrate)
por: Ganz, Tomas, et al.
Publicado: (2019)

A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
por: Hanudel, Mark R., et al.
Publicado: (2022)

Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
por: Chait, Yossi, et al.
Publicado: (2022)

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
por: Rodby, Roger A., et al.
Publicado: (2015)

Reduction of costs for anemia-management drugs associated with the use of ferric citrate
por: Thomas, Anila, et al.
Publicado: (2014)

Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
por: Gupta, Ajay
Publicado: (2014)

Ferric citrate is a safe and digestible source of iron in broilers and piglets
por: Männer, Klaus, et al.
Publicado: (2021)

Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli
por: Frick-Cheng, Arwen E., et al.
Publicado: (2022)

Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion
por: Schmidt, Carsten, et al.
Publicado: (2021)

Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease
por: Hanudel, Mark R., et al.
Publicado: (2022)

Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate
por: Marbury, Thomas, et al.
Publicado: (2022)

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study
por: Yokoyama, Keitaro, et al.
Publicado: (2022)

Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells
por: Scheers, Nathalie M., et al.
Publicado: (2018)

Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
por: Machida, Takuji, et al.
Publicado: (2022)

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate
por: Yokoyama, Keitaro, et al.
Publicado: (2017)

The fciTABC and feoABI systems contribute to ferric citrate acquisition in Stenotrophomonas maltophilia
por: Liao, Chun-Hsing, et al.
Publicado: (2022)

Low-phosphorus concentrations and important ferric hydroxide scavenging in Archean seawater
por: Rego, Eric Siciliano, et al.
Publicado: (2023)

Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
por: Wu, Mei-Yi, et al.
Publicado: (2017)

Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
por: Pratt, Raymond D., et al.
Publicado: (2018)

Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers
por: Pratt, Raymond D., et al.
Publicado: (2016)

Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
por: Kobayashi, Hiroshi, et al.
Publicado: (2022)

Ferric citrate and apo-transferrin enable erythroblast maturation with β-globin from hemogenic endothelium
por: Jeon, Soo-Been, et al.
Publicado: (2023)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study
por: Yokoyama, Keitaro, et al.
Publicado: (2019)

Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain
por: Guo, Xueling, et al.
Publicado: (2017)

Ferric Ammonium Citrate Upregulates PD-L1 Expression through Generation of Reactive Oxygen Species
por: Choi, Eun Jung, et al.
Publicado: (2022)

The effects of feeding ferric citrate on ruminal bacteria, methanogenic archaea and methane production in growing beef steers
por: Clemmons, Brooke A., et al.
Publicado: (2020)

Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
por: Liesen, Michael P., et al.
Publicado: (2022)

Current Management of Hyperkalemia in Patients on Dialysis
por: Bansal, Shweta, et al.
Publicado: (2020)

Effects of Chlorella vulgaris on phosphorus release from ferric phosphate sediment by consecutive cultivations
por: He, Lile, et al.
Publicado: (2022)

The effect of niacin on serum phosphorus levels in dialysis patients
por: Edalat-Nejad, M., et al.
Publicado: (2012)

Non-Transferrin-Bound Iron (NTBI) Uptake by T Lymphocytes: Evidence for the Selective Acquisition of Oligomeric Ferric Citrate Species
por: Arezes, Joao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_anr9dc4t2gegc850u72q2a0l6t